Login | Register
IAM Life Sciences: Key issues for senior life sciences executives 2020
IAM Life Sciences: Key issues for senior life sciences executives 2020
The key IP issues that entities operating in the pharmaceutical and biotechnology industries...

Articles

Patenting artificial intelligence in the life sciences: a practical guide

Caroline Pallard, Harm van der Heijden, Damien Bertrand and Thibault Helleputte
NLO

Deadly pitfalls and lessons learned – claiming priority at the EPO

Arwed Burrichter, Natalie Kirchhofer and Andreas Spinnrock
COHAUSZ & FLORACK

Patent issues in CAR-T technology

James F Haley Jr, Karen Mangasarian and Brian M Gummow
Haley Guiliano LLP

A guide for second medical use claims in Brazil

Gabriela Salerno and Mônica Gurvitz
Montaury Pimenta, Machado & Vieira de Mello

Patenting personalised medicine in Canada: navigating choppy waters

Jennifer A Marles and Christina SW Kwok
Oyen Wiggs Green & Mutala LLP

Making sense of the doctrine of equivalents in pharmaceutical patent litigation

Aaron F Barkoff and Ben J Mahon
McAndrews Held & Malloy

Second medical use inventions – Russian and Eurasian patent legislation

Lev Zhilin
Gorodissky & Partners

Doctrine of equivalents for life science patents in China

Yuan Zhang and Zongliang (Stephen) Zou
Liu Shen & Associates

Navigating the therapeutics market in Australia: the role of intellectual property

Kathryn Morris, Malcolm Lyons and Renee White
Griffith Hack

Biologics and biosimilars in Brazil – the strategic questions

Anderson Ribeiro, Priscila Kashiwabara and Aline Ferreira
Kasznar Leonardos

Unlock unlimited access to all IAM content

Subscribe Now